CALCIUM DURA Vit D3 Effervescent 600 mg/400 I.U., 50 pcs

Instructions for use for CALCIUM DURA Vit D3 Effervescent 600 mg/400 I.U., 50 pcs

Directions for use of the article Calcium Dura Vit D3 Effervescent 600 mg/400 I.U.: Calcium Dura Vit D3 Effervescent 600 mg/400 I.U. is a vitamin-mineral combination used to treat calcium and vitamin D3 deficiency and to support the treatment of osteoporosis. The effervescent tablets contain calcium carbonate and colecalciferol (vitamin D3) as active ingredients. The recommended dose is 1 effervescent tablet 2 times a day. The tablet is dissolved in a glass of water and drunk immediately. The medicine should be taken in the morning and evening. The duration of use is determined by the doctor. The medicine should not be used in children and adolescents under 18 years of age. There are some contraindications to its use. The medicine should not be taken if one is hypersensitive to calcium carbonate or vitamin D, there are high calcium concentrations in the blood or increased calcium excretion in the urine, there are kidney stones or calcium deposits in the kidneys, there is kidney dysfunction or parathyroid disease, or there is vitamin D overdose. Pregnant women should only take one effervescent tablet per day. Possible side effects include increased calcium levels, increased calcium excretion in the urine, constipation, flatulence, abdominal pain, nausea, hives, itching, skin rash and shift of the acid-base balance in the blood to the alkaline side. In case of overdose, other symptoms may occur such as increased thirst, increased urine output, abdominal pain, constipation, nausea, vomiting and muscle weakness. The medicine should be kept out of the reach of children and should not be disposed of in the sewage system. For more information on disposal, see www.bfarm.de/arzneimittelentsorgung. The package leaflet should be read and the doctor or pharmacist consulted if there are any questions. The medicinal product also contains various excipients such as DL-alpha-tocopherol, soya oil, sucrose and sorbitol. Persons with allergies to these ingredients should exercise caution. The medicinal product should be stored away from heat and moisture. The information is based on the information in the package leaflet and is valid as of January 2022. Further information can be found on the manufacturer's website VIATRIS HEALTHCARE . Important information: - The medicinal product contains sucrose, sorbitol, partially hydrogenated soya oil and sodium compounds. - The medicine is not suitable for children and adolescents under 18 years of age. - In case of overdose, symptoms such as increased thirst, increased urine output, abdominal pain and muscle weakness may occur. - The medicine should be stored away from heat and moisture. - Caution should be exercised in case of allergies to certain ingredients. - The package leaflet should be read and the doctor or pharmacist consulted if there are any questions. - For more information on disposal, see www.bfarm.de/arzneimittelentsorgung.